Home › Steatotic Liver Disease › Washington
Steatotic Liver Disease clinical trials in Washington
7 studies for Steatotic Liver Disease are looking for participants at sites in Washington.
Cities in Washington
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
- Washington Gastroenterology - Bellevue, Bellevue
- UW Medicine Diabetes Institute, Seattle
- Washington Gastroenterology - Tacoma, Tacoma
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT07165028A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
- Akero Clinical Study Site, Seattle
RecruitingPhase 3
Ages 18 to 80 · All sexes · Updated Sep 21, 2026 · NCT06528314A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASH
- GSK Investigational Site, Seattle
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Sep 17, 2026 · NCT07221188A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
- 89bio Clinical Study Site, Bellevue
- 89bio Clinical Study Site, Seattle
- 89bio Clinical Study Site, Seattle
- and 1 more
RecruitingPhase 3
Ages 18 to 80 · All sexes · Updated Sep 3, 2026 · NCT06318169A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
- 89bio Clinical Study Site, Bellevue
- 89bio Clinical Study Site, Seattle
- 89bio Clinical Study Site, Seattle
- and 1 more
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Sep 3, 2026 · NCT06419374A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH
- GSK Investigational Site, Seattle
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Jul 27, 2026 · NCT07221227Development of a Quantifiable Ultrasound Biomarker for Hepatic Steatosis
- University of Washington, Seattle
RecruitingHealthy volunteers welcome
Ages 18 to 75 · All sexes · Updated Dec 8, 2025 · NCT07270601From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.